sales reported Bt7,116mn, increasing 8.9%YoY but decreasing -27%QoQ. Sim & Device margin remained positive at +2.7%, compared to +2.5% in 2Q20 and +0.6% in 1Q21 due to more efficient subsidy. Cost
/month) Postpaid 15.1 17.0 18.8 24% 10% Prepaid 10.1 13.8 16.3 60% 18% Blended 11.5 14.7 17.0 47% 15% Device Penetration 4G-handset penetration 66% 74% 75% - - Fixed Broadband Business FBB subscribers
started its positive contribution to NPAT. Continued growth in digital services AIS digital services continued to scale in size focusing on growing user base both in consumer segment and enterprise
104 105 -11% 0.5% VOU (GB/data sub/month) Postpaid 16.6 19.8 21.6 30% 8.9% Prepaid 11.1 16.1 16.5 47% 2.4% Blended 12.7 17.2 18.0 42% 5.0% Device Penetration 4G-handset penetration 71% 76% 77% - - Fixed
their services to all customers. The Company, leading distributor of medical device, is developing new products; medical software, together with plan to shift from distributor to manufacture to serve
their services to all customers. The Company, leading distributor of medical device, is developing new products; medical software, together with plan to shift from distributor to manufacture to serve
, medical device business is expected to be growth at an average rate of 8.5-10.0% per year. This growth will be supported by: (i) government policy, focused on promoting investment in the sector through the
continued intense competition. The postpaid segment further developed a positive momentum and contributed a larger pie YoY in revenue share. Accelerated 5G users with superior network and service experiences
% -2.4% Prepaid 113 92 86 -24% -6.5% Blended 138 118 112 -19% -5.1% VOU (GB/data sub/month) Postpaid 14.4 16.6 17.0 18% 2.3% Prepaid 10.3 11.1 13.8 34% 23% Blended 11.4 12.7 14.7 29% 16% Device Penetration
% -2.4% Prepaid 113 92 86 -24% -6.5% Blended 138 118 112 -19% -5.1% VOU (GB/data sub/month) Postpaid 14.4 16.6 17.0 18% 2.3% Prepaid 10.3 11.1 13.8 34% 23% Blended 11.4 12.7 14.7 29% 16% Device Penetration